University of Seoul

Faculty

Department of Life Science, UOS
Associate Professor / Ph.D. / Chair
Dong-Sung Lee Dong-Sung Lee
  • OFFICE 2-217 / +82-2-6490-2676
  • LAB 2-B134 / +82-2-6490-5620
  • E-MAIL dslee@uos.ac.kr
  • RESEARCH
View More

Research introduction

Our laboratory is conducting research utilizing a variety of sequencing technologies on the Genome, Epigenome, Transcriptome, and more. We focus on performing experiments and analyses using techniques such as Genome sequencing, RNA-seq, ChIP-seq, ATAC-seq, Hi-C seq, bisulfite-seq, and also on developing new technologies.

Experimental Method Development
We have developed and published single nucleus methyl 3C sequencing (snm3C-seq), a single-cell multimodal-omics technique that allows for the simultaneous observation of more than two features from a single cell (Nature Methods 2019). This was selected as the Technology of the Year in 2019 and is currently being used in the Brain Initiative project to study the brain's epigenetic profile.

Analysis Tool Development
We are developing analysis methods for various sequencing techniques. Among them, we have particularly studied Structural Variants (SVs) in cancer cells using Hi-C sequencing, and the resultant changes in the three-dimensional structure of the genome and their impact on gene expression, which was published in 2022 (Nature 2022).
In addition, we have developed all basic analysis pipelines for snm3C, which we previously developed, from the alignment stage, and we continue to develop programs for basic analysis (Nature Methods 2019).

Education

  • 2015 Seoul National University, Ph.D. in Biomedical Sciences
  • 2010 Korea University, B.S. in Genetic Engineering

Career

  • 2020.09 - current: Univerisy of Seoul, Department of Life Science, Assistant Professor
  • 2016.05 - 2020. 08: Salk Institute for Biological Studies, Post-doctoral Researcher
  • 2015.03 - 2016.04: Genomic Medicine Institute, Seoul National University, Post-doctoral Researcher

Papers

  1. [2023.07] Hur J, Kim H, Kim U, Kim GB, Kim J, Joo B, Cho D, Lee DS*, Chung AJ. Genetically Stable and Scalable Nanoengineering of Human Primary T Cells via Cell Mechanoporation. doi: 10.1021/acs.nanolett.3c01720. Nano Letters
  2. [2022.12] Xu Z, Lee DS*, Chandran S, Le VT, Bump R, Yasis J, Dallarda S, Marcotte S, Clock B, Haghani N, Cho CY, Akdemir KC, Tyndale S, Futreal PA, McVicker G, Wahl GM, Dixon JR. Structural variants drive context-dependent oncogene activation in cancer. doi: 10.1038/s41586-022-05504-4. Nature
  3. [2023.05] Nam CH, Youk J, Kim JY, Lim J, Park JW, Oh SA, Lee HJ, Park JW, Jeong SY, Lee DS*, Oh JW, Han J, Lee J, Kwon HW, Kim MJ, Ju YS. Widespread somatic L1 retrotransposition in normal colorectal epithelium. doi: https://doi.org/10.1038/s41586-023-06046-z. Nature
  4. [2019.10] Lee DS*, Luo C*, Zhou J*, Chandran S, Rivkin A, Bartlett A, Nery JR, Fitzpatrick C, O’Connor C, Dixon JR, Ecker JR. Simultaneous profiling of 3D genome structure and DNA methylation in single human cells. doi: 10.1038/s41592-019-0547-z. Nature Methods.
  5. [2014.12] Lee DS*, Shin JY, Tonge PD, Puri MC, Lee S, Park H, Lee WC, Hussein SM, Bleazard T, Yun JY, Kim J, Li M, Cloonan N, Wood D, Clancy JL, Mosbergen R, Yi JH, Yang KS, Kim H, Rhee H, Wells CA, Preiss T, Grimmond SM, Rogers IM, Nagy A, Seo JS. An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator. doi: 10.1038/ncomms6619 Nature Commun